State Street SPDR S&P Biotech ETF (XBI) Dernières nouvelles, mises à jour du marché et sentiment | Edgen
Retour
Accueil
Stock
XBI
State Street SPDR S&P Biotech ETF (XBI)
Graphique du cours de l'action XBI
XBI
State Street SPDR S&P Biotech ETF
$162.36
-3.48%
$-5.86
À partir d'aujourd'hui :Aug 28, 14:41:52 GMT-4
Aperçu
Prévision
Positions
Actualités
Article
Statistiques clés
Clôture préc.
$168.23
Prix d'ouverture
$166.72
Plage de la journée
$162.34 - $167.12
Plage de 52 semaines
$88.18 - $169.68
Volume
7.3M
Volume moyen
8.6M
Rendement en dividend
0.37%
Actifs nets
$0
NAV
--
Ratio des frais
--
Parts sociales en circulation
64.5M
Qu’est-ce que XBI ?
XBI was created on 2006-01-31 by SPDR. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 10424.49m in AUM and 148 holdings. XBI tracks an equal-weighted index of US biotechnology stocks.
Fonctionnalités
Copilote IA pour actions et cryptomonnaies
Prédiction des prix
Suivi des collectes de fonds
Comparaison de cryptomonnaies
Page d'accueil
Markets
US Stocks
HK Stocks
Crypto
News
Analyst Moves
Market Moves
Hong Kong IPO
Earnings
AI & Technology
Macro & Policy
Conditions d’utilisation
Politique de confidentialité
Plan du site
© 2026 Edgen fonctionné par
Oruka Therapeutics jumps 65% on psoriasis drug trial momentum
Aug 28 2026, 16:31
Moderna prices $2.6 billion convertible notes to fund oncology push
Aug 28 2026, 12:25
Biotech's 85% rally faces China's fast-follower drug threat
Aug 28 2026, 12:09
FDA approves Rasonque, nearly doubling pancreatic cancer survival to 13 months
Aug 26 2026, 16:02
Moderna surges 177% as cancer vaccine hype outruns the math
Aug 26 2026, 05:51
Moderna's $69.6B war chest opens door to 4 biotech targets
Aug 20 2026, 13:59
Moderna stock surges 177% as cancer vaccine clears Phase 3 trial
Aug 20 2026, 11:42
Moderna mRNA cancer vaccine clears Phase 3, CanSino jumps 50%
Aug 20 2026, 11:24
S&P 500 gains 0.2% as Treasury buyback expansion eases yields
Aug 20 2026, 00:23
Moderna, Merck melanoma vaccine hits Phase 3 goals, shares surge 40%
Aug 19 2026, 11:43
Aug 10 2026, 00:00
Aug 10 2026, 00:00
Aug 10 2026, 00:00
Aug 10 2026, 00:00
Aug 10 2026, 00:00
Aug 10 2026, 00:00
Aug 10 2026, 00:00
Aug 10 2026, 00:00